Clinical Trials

Clinical Trials for MTG3

Filter list of Clinical Trials

TopicTrial name of investigational drugClinical Trial ID(s)StatusOrphaCodeLink
Diabetes MellitusASCEND: A Study of Cardiovascular Events in Diabetes
  • NCT00135226
  • ongoing
  • ORPHA101952
Type 1 Diabetes MellitusStudy of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects (CCFZ533X2207)
  • NCT04129528
  • ongoing
  • recruitment
  • ORPHA181371
Type 1 Diabetes MellitusKidsAP02
  • KIDSAP consortium
  • ongoing
  • ORPHA181371
Type 1 Diabetes MellitusInitiative pour la Promotion de la Qualité et Epidémiologie chez les Enfants et Adolescents atteints du Diabète sucré (IPQE-EAD
  • IPQE-EAD
  • IKEKAD
  • ongoing
  • ORPHA181371
Type 1 Diabetes MellitusA randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5).
  • NCT02825251
  • completed
  • ORPHA181371
Type 1 Diabetes MellitusEvaluation of the Dreamed Advisor Pro for Automated Insulin Pump Setting Adjustments in Children and Adolescents With Type 1 Diabetes- The Advice4U Pro Study
  • NCT03003806
  • completed
  • ORPHA181371
Type 1 Diabetes MellitusFLAIR- Fuzzy Logic Automated Insulin Regulation: 3 A Crossover Study Comparing Two Automated Insulin Delivery System 4 Algorithms (PID vs. PID + Fuzzy Logic) in Individuals with Type 1 Diabetes
  • NCT03040414
  • completed
  • ORPHA181371
Type 1 Diabetes MellitusDiagnode 2 - GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes
  • NCT03345004
  • concluded
  • ORPHA181371
Type 1 Diabetes MellitusPhase 3, Randomized, Double-blind, Placebo/Active-controlled, Parallel-arm Trial to Assess Efficacy, Safety, and Pharmacokinetics of Dasiglucagon Relative to Placebo/GlucaGen® as Rescue Therapy for Severe Hypoglycemia in Children With T1DM Treated With Insulin
  • NCT03667053
  • completed
  • ORPHA181371
Type 1 Diabetes MellitusA Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes (PRONTO-Peds)
  • NCT03740919
  • concluded
  • ORPHA181371
Type 1 Diabetes MellitusThe Artificial Pancreas in Very Young Children With T1D (KidsAP02)
  • NCT03784027
  • completed
  • ORPHA181371
Type 1 Diabetes MellitusA Phase 3, Randomized, Double-Blind, Multinational, Placebo-Controlled Study to Evaluate Efficacy and Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, anti-CD3 Monoclonal Antibody, in Children and Adolescents with Newly Diagnosed Type 1 Diabetes (T1D)
  • NCT03875729
  • PRV-031-001
  • ongoing
  • ORPHA181371
Type 2 Diabetes MellitusDiabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM
  • NCT03429543
  • ongoing
  • ORPHA181376
Type 2 Diabetes MellitusA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Clinical Study to Evaluate the Safety and Efficacy of Ertugliflozin (MK-8835/PF-04971729) in Pediatric Participants (ages 10 to 17 years, inclusive) with Type 2 Diabetes Mellitus
  • NCT04029480
  • MK8835-059
  • ongoing
  • recruiting
  • ORPHA181376
Natriuretic Peptides,ObesityThe Diurnal Rhythm in Natriuretic Peptide Levels and Relationship With Nocturnal Blood Pressure
  • NCT03834168
  • ongoing
Type 1 Diabetes MellitusLA Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy (PRONTO-Pump-2)
  • NCT03830281
  • completed
  • ORPHA181371
Wolfram SyndromeTreatment Trial (in preparation): An international, randomised, double-blind, efficacy and safety trial of GLP-1 receptor agonist (e.g. Liraglutide) treatment in paediatric and adult patients with Wolfram Syndrome to control neurodegeneration and hyperglycaemia
  • NCT03717909
  • ongoing
  • ORPHA3463
Congenital HyperinsulinismAn Open-Label Multiple-Dose Study of RZ358 in Patients with Congenital Hyperinsulinism”. Estudio abierto de dosis múltiples de RZ358 en pacientes con hiperinsulinismo congénito.
  • EudraCT 2016-004186-83
  • CODIGO RZ358-606. RZ358 - 606
  • ongoing
  • results
  • ORPHA657
Congenital HyperinsulinismA Two-Period, Open-label Trial Evaluating the Efficacy and Safety of Dasiglucagon for the Treatment of Children with Congenital Hyperinsulinism
  • NCT03777176
  • completed
  • ORPHA657
Congenital HyperinsulinismAn Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon for the Treatment of Children with Congenital Hyperinsulinism
  • NCT03941236
  • ongoing
  • ORPHA657
Congenital HyperinsulinismTrial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism
  • NCT04172441
  • completed
  • ORPHA657
Congenital HyperinsulinismAn Open-Label Multiple-Dose Study of RZ358 in Patients with Congenital Hyperinsulinism, Protocol RZ358-606
  • NCT04538989
  • RZ358-606
  • ongoing
  • recruiting
  • ORPHA657
Diabetic Foot Ulcer (DFU)A randomized, placebo-controlled, double-blind study to evaluate safety and dose dependent clinical efficacy of APO-2 at three different doses in patients with diabetic foot ulcer (MARSYAS II)
  • NCT04277598
  • MARSYAS II
  • APO-2
  • ongoing
  • ORPHA181371
  • ORPHA181376
Type 1 Diabetes MellitusStudy of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects (CCFZ533X2207)
  • NCT04129528
  • ongoing
  • recruitment
  • ORPHA181371
TopicTrial name of investigational drugClinical Trial ID(s)StatusOrphaCodeLink

An overview of all Clinical Trials can be found here.